Health
FDA Updates Menopause Therapy Guidance
Health Points
- The FDA is removing the “black box” warning from hormone replacement therapy (HRT) used for menopause.
- New labels will offer age-specific advice, with a focus on potential long-term health benefits if treatment begins within a decade of menopause onset.
- Two new menopause symptom treatments, including a nonhormonal option, are getting FDA approval.
The FDA’s decision means HRT for menopause will no longer carry the strictest safety warning on its packaging. Instead, guidance will focus on how starting therapy within 10 years of menopause could offer lasting health benefits.
This update follows years of debate about HRT safety and potential cancer or heart risks. Some doctors welcome the change, while others feel more research was needed before dropping the warning.
For more on managing menopause with confidence, stay tuned to the latest health updates and talk with your provider about what’s right for you.